SynopsisAarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue. The rally was further supported by a Rs 149-crore capex plan to add 405 KL of capacity for its CDMO and intermediate businesses.